Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01948518 · ClinicalTrials.gov registry record · NA
Effect of Sildenafil on Diffusion Capacity in Patients With PH and Parenchymal Lung Disease
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT01948518 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 15 participants.
The verdict
NCT01948518, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study was to investigate the acute effects of sildenafil on diffusion capacity, a commonly performed pulmonary function test, which is used to assess the lungs' gas exchange capability. This study does not assess safety or efficacy of the drug. The study does not have clinical end points. The variables studied are diffusion capacity and 6 minute walk after a single dose of sildenafil. This study has been completed.
Interventions
- DRUG Oral sildenafil 20 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-06 |
| Est. Completion | 2012-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01948518
The ClinicalTrials.gov registry entry for NCT01948518 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral sildenafil 20 mg is the first listed.
NCT01948518 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01948518 about?
NCT01948518 is a clinical study titled "Effect of Sildenafil on Diffusion Capacity in Patients With PH and Parenchymal Lung Disease". The purpose of this study was to investigate the acute effects of sildenafil on diffusion capacity, a commonly performed pulmonary function test, which is used to assess the lungs' gas exchange capability. This study does not assess safety or efficacy of the drug. The study does not have clinical e...
What is the current status of trial NCT01948518?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2009-06. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01948518?
The interventions under investigation include: Oral sildenafil 20 mg (DRUG).
Who is sponsoring clinical trial NCT01948518?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.